A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Rationale and Objective Glomerular filtration rate (GFR) estimation based on creatinine and cystatin C (eGFR cr-cys ) is more accurate than estimated GFR (eGFR) based on creatinine or cystatin C alone (eGFR cr or eGFR cys , respectively), but the inclusion of creatinine in eGFR cr-cys requires specification of a person's race. β 2 -Microglobulin (B2M) and β-trace protein (BTP) are alternative filtration markers that appear to be less influenced by race than creatinine is. Study Design Study of diagnostic test accuracy. Setting and Participants Development in a pooled population of 7 studies with 5,017 participants with and without chronic kidney disease. External validation in a pooled population of 7 other studies with 2,245 participants. Tests Compared Panel eGFR using B2M and BTP in addition to cystatin C (3-marker panel) or creatinine and cystatin C (4-marker panel) with and without age and sex or race. Outcomes GFR measured as the urinary clearance of iothalamate, plasma clearance of iohexol, or plasma clearance of [ 51 Cr]EDTA. Results Mean measured GFRs were 58.1 and 83.2 mL/min/1.73 m 2 , and the proportions of Black participants were 38.6% and 24.0%, in the development and validation populations, respectively. In development, addition of age and sex improved the performance of all equations compared with equations without age and sex, but addition of race did not further improve the performance. In validation, the 4-marker panels were more accurate than the 3-marker panels ( P < 0.001). The 3-marker panel without race was more accurate than eGFR cys (percentage of estimates greater than 30% different from measured GFR [1 − P 30 ] of 15.6% vs 17.4%; P = 0.01), and the 4-marker panel without race was as accurate as eGFR cr-cys (1 − P 30 of 8.6% vs 9.4%; P = 0.2). Results were generally consistent across subgroups. Limitations No representation of participants with severe comorbid illness and from geographic areas outside of North America and Europe. Conclusions The 4-marker panel eGFR is as accurate as eGFR cr-cys without requiring specification of race. A more accurate race-free eGFR could be an important advance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Self-citationEstimating glomerular filtration rate from serum creatinine and cystatin C
Inker, L. A., Schmid, C. H., Tighiouart, H., Eckfeldt, J. H., Feldman, H. I., Greene, T., Kusek, J. W., Manzi, J., Van Lente, F., Zhang, Y. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114248 · Cited by 4,102
Self-citationAssessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952
Self-citationHidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms
Vyas, D. A., Eisenstein, L. G., & Jones, D. S. (2020) · New England Journal of Medicine · doi:10.1056/nejmms2004740 · Cited by 1,731
Reconsidering the Consequences of Using Race to Estimate Kidney Function
Eneanya, N. D., Yang, W., & Reese, P. P. (2019) · JAMA · doi:10.1001/jama.2019.5774 · Cited by 385
Risch, L., Herklotz, R., Blumberg, A., & Huber, A. R. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.11.2055 · Cited by 343
Cited by
New creatinine- and cystatin C-based equations to estimate GFR without race
Inker, L. A., Eneanya, N. D., Coresh, J., Tighiouart, H., Wang, D., Sang, Y., Crews, D. C., Doria, A., Estrella, M. M., Froissart, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102953 · Cited by 4,695
Self-citationDelgado, C., Baweja, M., Crews, D. C., Eneanya, N. D., Gadegbeku, C. A., Inker, L. A., Mendu, M. L., Miller, W. G., Moxey-Mims, M. M., Roberts, G. V., et al. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.08.003 · Cited by 783
Self-citationDelgado, C., Baweja, M., Crews, D. C., Eneanya, N. D., Gadegbeku, C. A., Inker, L. A., Mendu, M. L., Miller, W. G., Moxey-Mims, M. M., Roberts, G. V., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021070988 · Cited by 423
Self-citationLong-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
Colhoun, H. M., Lingvay, I., Brown, P. M., Deanfield, J., Brown-Frandsen, K., Kahn, S. E., Plutzky, J., Node, K., Parkhomenko, A., Rydén, L., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03015-5 · Cited by 238
“Blood samples were collected at screening, at weeks 20, 52, 104, 156 and 208, and at the end of treatment. eGFR values were calculated centrally based on serum creatinine using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2009 creatinine equation 51 , with sensitivity analyses…”
MethodHealth inequities and the inappropriate use of race in nephrology
Eneanya, N. D., Boulware, L. E., Tsai, J., Bruce, M. A., Ford, C. L., Harris, C., Morales, L. S., Ryan, M. J., Reese, P. P., Thorpe, R. J., et al. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00501-8 · Cited by 140
Metadata
- Authors
- Inker, L. A., Couture, S. J., Tighiouart, H., Abraham, A. G., Beck, G. J., Feldman, H. I., Greene, T., Gudnason, V., Karger, A. B., Eckfeldt, J. H., Kasiske, B. L., Mauer, M., Navis, G., Poggio, E. D., Rossing, P., Shlipak, M. G., Levey, A. S., Andresdottir, M. B., Gudmundsdottir, H., Indridason, O. S., Palsson, R., Kimmel, P., Weir, M., Kalil, R., Pesavento, T., Porter, A., Taliercio, J., Hsu, C.-Y., Chen, J., Sinkeler, S., Wyatt, C., Krishnasami, Z., Hellinger, J., Margolick, J., Kingsley, L., Witt, M., Wolinsky, S., Shafi, T., Post, W., Doria, A., & Parving, H.-H.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 77
- Issue
- 5
- Pages
- 673-683.e1
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W3111410489
- Cited by
- 78
- References
- 6
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population. https://app.cochat.ai/papers/10.1053/j.ajkd.2020.11.005
- The paper
- Inker, L. A., Couture, S. J., Tighiouart, H., Abraham, A. G., Beck, G. J., Feldman, H. I., Greene, T., Gudnason, V., Karger, A. B., Eckfeldt, J. H., Kasiske, B. L., Mauer, M., Navis, G., Poggio, E. D., Rossing, P., Shlipak, M. G., Levey, A. S., Andresdottir, M. B., Gudmundsdottir, H., . . . Parving, H.-H. (2021). A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population. American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2020.11.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.